We are monitoring the impact of COVID-19 on North America Active Implantable Medical Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4849
Share on
Share on

North America Active Implantable Medical Devices Market Research Report – Segmented By Product & By Country (US, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4849
Pages: 145

North America Active Implantable Medical Devices Market Size (2021 to 2026):

The size of the North America Active Implantable Medical Devices Market has been estimated at USD 8.05 billion in 2021 and is expected to reach USD 11.58 billion by 2026, registering a CAGR of 7.53% between 2021 to 2026.

Medical Device (AIMD) Directive 90385EEC defines an active implantable medical device as any active implantable medical device refers to any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure

The demand for active implantable medical devices is increasing due to increasing occurrences of cardiovascular diseases and increasing incidences of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world. Implantable cardioverter defibrillators and implantable cardiac pacemakers are the key medical devices used for the treatment of different cardiovascular conditions. The high occurrence of cardiovascular diseases depicts increased demand for these devices.

According to the Parkinson’s disease Foundation (PDF), approximately 7 million to 10 million people across the globe have Parkinson’s disease. Similarly, according to PDF approximately 60,000 new cases of Parkinson’s disease are reported each year in the U.S. High incidence of neurological disorders fuels the demand for neurostimulators, which further drives the global active implantable medical devices market. The healthcare industry in emerging economies has witnessed significant growth over the past few years. The healthcare market size in the emerging economies is still a fraction of that in developed countries.

The massive unexplored active implantable medical devices market would create ample revenue generation opportunities for the active implantable medical device manufacturers. The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. The countries such as China and India have a large population base and the healthcare infrastructure in these countries is improving, thus illustrating immense healthcare market potential.

Manufacturing medical devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality. With the increasing income level and the increasing compliance for high-quality implants, the demand for active implantable medical devices is expected to increase in these countries.

This research report on North American Active Implantable Medical Devices Market has been segmented and sub-segmented into the following categories:

  • By Product: Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices)
  • By Country: US, Canada & Rest of North America.

On the basis of product, the Single-chamber implantable cardioverter defibrillators accounted for the largest share in this market segment followed by subcutaneous implantable cardioverter defibrillators. The neurostimulators market is projected to witness the highest growth rate in this market segment.

On the basis of region, North America held the largest share in the regional segment of the market. The large share of this regional segment can be credited to the growth in the geriatric population, the surge in the occurrence of cardiovascular and neurological diseases, high accessibility to advanced technologies, rise in the development of innovative and technologically advanced products, and rise in the healthcare expenditure in the region.

Some of the major companies dominating the North America Active Implantable Medical Devices Market Profiled in the Report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Implantable Cardioverter Defibrillators                      

                                                5.1.2.1 Transvenous Implantable Cardioverter Defibrillators        

                                                                5.1.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

                                                                5.1.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators

                                                                5.1.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators

                                                5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillator       

                                5.1.3 Implantable Cardiac Pacemakers                   

                                5.1.4 Ventricular Assist Devices                 

                                5.1.5 Implantable Heart Monitors/Insertable Loop Recorders                     

                                5.1.6 Neurostimulators                 

                                                5.1.6.1 Spinal Cord Stimulators  

                                                5.1.6.2 Deep Brain Stimulators  

                                                5.1.6.3 Sacral Nerve Stimulators               

                                                5.1.6.4 Vagus Nerve Stimulators               

                                                5.1.6.5 Gastric Electrical Stimulators        

                                5.1.7 Implantable Hearing Devices                           

                                                5.1.7.1 Active Hearing Implants 

                                                5.1.7.2 Passive Hearing Implants              

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                6.2 United States                                            

                6.3 Canada                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Medtronic plc                                            

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Abbott Laboratories                                               

                8.3 Boston Scientific Corporation                                             

                8.4 BIOTRONIK SE & Co. KG                                        

                8.5 LivaNova PLC.                                            

                8.6 Cochlear Limited                                      

                8.7 MED-EL                                        

                8.8 Sonova Holding AG                                 

                8.9 William Demant Holding A/S                                               

                8.10 Nurotron Biotechnology Co. Ltd.                                    

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the region-wise market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. North America Active Implantable Medical Devices Market, By Product, From 2021 to 2026 (USD Billion)
  2. North America Implantable Cardioverter Defibrillators Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America Cardiac Pacemaker Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Ventricular Assist Device Market, By Region, From 2021 to 2026 (USD Billion)
  5. North America Neurostimulator Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Implantable Hearing Devices Market, By Region, From 2021 to 2026 (USD Billion)
  7. United States Active Implantable Medical Devices Market, By Product, From 2021 to 2026 (USD Billion)
  8. Canada Active Implantable Medical Devices Market, By Product, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample